2024 Influenza Vaccines

The Australian Influenza Vaccine Committee (AIVC) has recommended the composition of the influenza vaccines for Australia in 2024 following review and evaluation of epidemiology, antigenic and genetic data of recent influenza viruses circulating in Australia and the southern hemisphere.

Further information is available on the TGA website.

Egg-based quadrivalent influenza vaccines AIVC recommendations:

  • an A/Victoria/4897/2022 (H1N1)pdm09-like virus; NEW
  • an A/Thailand/8/2022 (H3N2)-like virus; NEW
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

Cell- or recombinant-based quadrivalent influenza vaccines AIVC recommendations:

  • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus; NEW
  • an A/Massachusetts/18/2022 (H3N2)-like virus; NEW
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

Resources on the 2024 influenza vaccination will be available ahead of the influenza vaccination program on the NSW Health website. Advice on when and how to order 2024 NIP influenza vaccines will be circulated in February 2024.

The current formulations of influenza vaccine that are available to order from the State Vaccine Centre (SVC) are 2023 influenza vaccines.

Please note the following expiration dates for 2023 influenza vaccines:

  • Vaxigrip Tetra: Expired on 31/12/2023 – DISCARD.
  • Fluarix Tetra: Expiring 29/02/2024 – monitor expiration date.
  • Afluria Quad: Expiring 29/02/2024 – monitor expiration date.
  • Fluad Quad: Expiring between 15/02/2024 and 17/02/2024 – monitor expiration date.


Share 2024 Influenza Vaccines on Facebook Share 2024 Influenza Vaccines on Twitter Share 2024 Influenza Vaccines on Linkedin Email 2024 Influenza Vaccines link